Shaanxi Kanghui Pharmaceutical Co., Ltd. (SHA:603139)

SHA:603139 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 3, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,360	1,434	1,875	1,773	2,174	1,676
Market Cap Growth	74.13%	-23.49%	5.75%	-18.47%	29.74%	-2.56%
Enterprise Value	2,970	2,067	2,467	2,149	2,371	1,534
Last Close Price	23.63	14.36	18.77	17.75	21.69	16.65
PE Ratio	-	-	-	-	59.60	49.13
Forward PE	-	23.05	23.05	23.05	23.05	23.05
PS Ratio	4.60	2.55	2.79	3.61	4.91	4.05
PB Ratio	3.17	1.58	1.84	1.73	1.95	1.56
P/TBV Ratio	3.84	1.94	2.26	2.10	2.40	1.94
P/FCF Ratio	49.90	-	-	-	-	-
P/OCF Ratio	28.93	38.46	-	35.15	293.09	17.88
EV/Sales Ratio	5.79	3.68	3.67	4.37	5.36	3.70
EV/EBITDA Ratio	-	-	64.58	125.09	68.44	33.20
EV/EBIT Ratio	-	-	1797.74	-	129.78	44.79
EV/FCF Ratio	62.80	-	-	-	-	-
Debt / Equity Ratio	0.90	0.70	0.66	0.53	0.44	0.07
Debt / EBITDA Ratio	-	-	17.18	31.66	14.30	1.67
Debt / FCF Ratio	14.12	-	-	-	-	-
Asset Turnover	0.26	0.28	0.35	0.27	0.28	0.34
Inventory Turnover	1.96	2.06	3.04	2.50	2.23	2.26
Quick Ratio	0.47	0.57	0.63	1.18	1.62	2.37
Current Ratio	0.79	1.00	1.00	1.61	2.09	2.94
Return on Equity (ROE)	-25.71%	-11.63%	-4.96%	-7.17%	3.02%	3.49%
Return on Assets (ROA)	-5.13%	-1.93%	0.04%	-0.28%	0.72%	1.75%
Return on Invested Capital (ROIC)	-11.60%	-4.11%	0.10%	-0.62%	1.43%	3.97%
Return on Capital Employed (ROCE)	-14.20%	-4.70%	0.10%	-0.60%	1.20%	3.00%
Earnings Yield	-7.79%	-6.25%	-1.40%	-3.56%	1.68%	2.04%
FCF Yield	2.00%	-0.65%	-7.71%	-4.95%	-13.01%	-10.25%
Dividend Yield	-	-	-	-	0.34%	0.42%
Payout Ratio	-	-	-	-	91.51%	29.25%
Buyback Yield / Dilution	0.60%	1.02%	-0.52%	-1.51%	1.73%	-0.89%
Total Shareholder Return	0.60%	1.02%	-0.52%	-1.51%	2.07%	-0.47%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.